Blood-Pressure Drug Cos. Hit With Suit Over Contamination
By Aaron Leibowitz ( November 8, 2018, 2:10 PM EST) -- The makers of a generic blood-pressure drug that was recalled due to contamination by a carcinogen "willfully ignored warning signs" about poor safety procedures in a laboratory in India and should have known their drugs were tainted years before testing revealed it this summer, according to a putative consumer class action filed Wednesday in Boston federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.